AUA: Immunotherapy Aids Survival in Muscle-Invasive Bladder Cancer; Patients receiving nivolumab had an approximately 30 percent lower likelihood of developing cancer recurrence versus placebo.

Media coverage

• Title	AUA: Immunotherapy Aids Survival in Muscle-Invasive Bladder Cancer; Patients receiving nivolumab had an approximately 30 percent lower likelihood of developing cancer recurrence versus placebo.
  Media name/outlet	Physician's Briefings
  Country/Territory	United States
  Date	17/05/22
  Persons	Matthew Galsky